Australian public assessment report for ChAdOx1-S - COVID ...

The vector is a chimpanzee adenovirus modified to avoid its replication. Previous clinical trials for a ChAdOx1 vectored vaccine have included those for influenza (fusion protein NP + M1), tuberculosis, prostate cancer, malaria, chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS-CoV) and meningitis. ................
................